共 50 条
- [32] Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway JOURNAL OF CANCER, 2024, 15 (03): : 659 - 670
- [33] CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway ONCOTARGETS AND THERAPY, 2018, 11 : 6209 - 6216